You are here: Home » Markets » News
Business Standard

Bal Pharma gains on foray into OTC segment

The company's arm as launched íts maiden OTC product 'Eye Spa'

SI Reporter  |  Mumbai 

Shares of were up over 5% at Rs 71 on the Bombay Stock Exchange after the company announced its foray into OTC (Over-the-counter) segment business through its subsidiary Lifezen Healthcare Pvt Ltd.

The company has launched its maiden OTC product 'Eye Spa' in the Bangalore market. 'Eye Spa' is an unique product which soothes and rejuvenates the tired eyes, due to their continuous exposure to dust, TV/computer screen, air conditioning and other modern lifestyle disorders, the company said in a release.

The stock opened at Rs 67.50 and touched a high of Rs 72.70 on the Bombay Stock Exchange. At 1:35PM, over 65,0000 shares were traded on both the stock exchanges.

First Published: Thu, September 10 2015. 13:36 IST